Sequencing Primer, XL39-R
CNY 570.00
货期*
4周
规格
Cited in 1 publication. |
Product images
Specifications
Product Data | |
sds_url | /sds/ge100137.pdf |
_pt | 1 |
components | 1 vial of lyophilized sequencing primer (1 nmol, sufficient for 100 sequencing reactions) |
_c | dna-sequencing-primer |
sub_category | DNA Sequencing Primers |
availabilities_filter | In Stock |
description | Reverse primer to sequence targets cloned in expression vectors. |
pdf_url | /datasheet/ge100137.pdf |
forward_seq | 5' ATTAGGACAAGGCTGGTGGG 3' |
storage | Store at -20°C. |
product_name | Sequencing Primer, XL39-R |
vector | PS100001, PS100002, PS100004, PS100005, PS100006, PS100007, PS100008, PS100009, PS100011, PS100012, PS100013, PS100014, PS100016, PS100017, PS100018, PS100019, PS100020, PS100022, PS100024, PS100025, PS100026, PS100033, PS100035, PS100047, PS100048, PS100049, PS100051, PS100052, PS100055, PS100056, PS100057, PS100058, PS100061, PS100066, PS100067, PS100089, PS100111 |
category | Gene Expression |
stability | The lyophilized and suspended primer is stable for one year from date of shipping when stored at -20°C |
sizes_filter | 1 nmol |
quality_control | The primer has been tested to generate satisfactory sequencing data on ABI 3730. |
Citations (1)
The use of this Gene Expression has been cited in the following citations: |
---|
Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma
,null,
Cancers
,PubMed ID 30909453
|
Documents
Resources
基因表达相关资源 |
Customer
Reviews
Loading...